메뉴 건너뛰기




Volumn 28, Issue SUPPL. 3, 2008, Pages 67-78

Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis);Alteraciones del metabolismo mineral en la enfermedad renal crónica estadios III, IV y v (no en diálisis)

Author keywords

Chronic kidney disease; Mineral metabolism; Treatment

Indexed keywords

ARTICLE; CHRONIC DISEASE; DISEASE COURSE; HUMAN; KIDNEY DISEASE; METABOLIC DISORDER; PRACTICE GUIDELINE;

EID: 51349116440     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (22)

References (57)
  • 1
    • 33847223412 scopus 로고    scopus 로고
    • Bellas) A y cols. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients
    • Block GA, Raggi P, Bellas) A y cols. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007.
    • (2007) Kidney Int
    • Block, G.A.1    Raggi, P.2
  • 2
    • 0034836578 scopus 로고    scopus 로고
    • Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients
    • Ganesh SK, Stack AG, Levin NW y cols. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12:2131-2138.
    • (2001) J Am Soc Nephrol , vol.12 , pp. 2131-2138
    • Ganesh, S.K.1    Stack, A.G.2    Levin, N.W.3
  • 3
    • 3042528668 scopus 로고    scopus 로고
    • Arterial calcifications and bone histomorphometry in end-stage renal disease
    • London GM, Marty C, Marchais SJ y cols. Arterial calcifications and bone histomorphometry in end-stage renal disease. JAm Soc Nephrol 2004; 15: 1943-1951.
    • (2004) JAm Soc Nephrol , vol.15 , pp. 1943-1951
    • London, G.M.1    Marty, C.2    Marchais, S.J.3
  • 4
    • 1542347890 scopus 로고    scopus 로고
    • Vascular calcification in chronic kidney disease
    • Goodman WG, London G, Amann K y cols. Vascular calcification in chronic kidney disease. Am J Kidney Dis 2004; 43: 572-579.
    • (2004) Am J Kidney Dis , vol.43 , pp. 572-579
    • Goodman, W.G.1    London, G.2    Amann, K.3
  • 5
    • 33645757920 scopus 로고    scopus 로고
    • Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
    • Moe S, Drueke T, Cunningham J y cols. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006; 69: 1945-1953.
    • (2006) Kidney Int , vol.69 , pp. 1945-1953
    • Moe, S.1    Drueke, T.2    Cunningham, J.3
  • 6
    • 0033983570 scopus 로고    scopus 로고
    • Race is a major determinant of secondary hyperparathyroidism in uremic patients
    • Gupta A, Kallenbach LR, Zasuwa G, Divine GW. Race is a major determinant of secondary hyperparathyroidism in uremic patients. J Am Soc Nephrol 2000; 11: 330-334.
    • (2000) J Am Soc Nephrol , vol.11 , pp. 330-334
    • Gupta, A.1    Kallenbach, L.R.2    Zasuwa, G.3    Divine, G.W.4
  • 7
    • 85047697721 scopus 로고
    • Adynamic bone disease with negative aluminium staining in predialysis patients: Prevalence and evolution after maintenance dialysis
    • Hernández D, Concepcion MT, Lorenzo V y cols. Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis. Nephrol Dial Transplant 1994; 9: 517-523.
    • (1994) Nephrol Dial Transplant , vol.9 , pp. 517-523
    • Hernández, D.1    Concepcion, M.T.2    Lorenzo, V.3
  • 8
    • 0035020803 scopus 로고    scopus 로고
    • Parathyroidectomy in patients on renal replacement therapy: An epidemiologic study
    • Malbertl F, Marcelli D, Conte F y cols. Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study. J Am Soc Nephrol 2001; 12: 1242-1248.
    • (2001) J Am Soc Nephrol , vol.12 , pp. 1242-1248
    • Malbertl, F.1    Marcelli, D.2    Conte, F.3
  • 9
    • 0027178439 scopus 로고
    • The spectrum of bone disease in end-stage renal failure -an evolving disorder
    • Sherrard DJ, Hercz G, Pei Y y cols. The spectrum of bone disease in end-stage renal failure -an evolving disorder. Kidney Int 1993; 43: 436-442.
    • (1993) Kidney Int , vol.43 , pp. 436-442
    • Sherrard, D.J.1    Hercz, G.2    Pei, Y.3
  • 10
    • 0029036314 scopus 로고
    • Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTH
    • Torres A, Lorenzo V, Hernández D y cols. Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. Kidney Int 1995; 47: 1434-1442.
    • (1995) Kidney Int , vol.47 , pp. 1434-1442
    • Torres, A.1    Lorenzo, V.2    Hernández, D.3
  • 11
    • 0032983878 scopus 로고    scopus 로고
    • Phosphorus, regulation of plasma calcium, and secondary hyperparathyroidism: A hypothesis to integrate a historical and modern perspective
    • Felsenfeld AJ, Rodríguez M. Phosphorus, regulation of plasma calcium, and secondary hyperparathyroidism: a hypothesis to integrate a historical and modern perspective. J Am Soc Nephrol 1999; 10: 878-890.
    • (1999) J Am Soc Nephrol , vol.10 , pp. 878-890
    • Felsenfeld, A.J.1    Rodríguez, M.2
  • 12
    • 20544431807 scopus 로고    scopus 로고
    • Calcium, phosphorus and vitamin Ddisordersin uremia
    • Slatopolsky E, Brown A, Dusso A. Calcium, phosphorus and vitamin Ddisordersin uremia. Contrib Nephrol 2005; 149: 261-271.
    • (2005) Contrib Nephrol , vol.149 , pp. 261-271
    • Slatopolsky, E.1    Brown, A.2    Dusso, A.3
  • 13
    • 34247844331 scopus 로고    scopus 로고
    • The Calcimimetic R-568 increases vitamin D receptor expression In rat parathyroid glands
    • Rodriguez M, Almadén Y, Canadillas S y cols. The Calcimimetic R-568 increases vitamin D receptor expression In rat parathyroid glands. Am J Physiol Renal Physiol 2007.
    • (2007) Am J Physiol Renal Physiol
    • Rodriguez, M.1    Almadén, Y.2    Canadillas, S.3
  • 14
    • 85133388134 scopus 로고    scopus 로고
    • Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005; 289: F8-28.
    • Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005; 289: F8-28.
  • 15
    • 0025005903 scopus 로고
    • Renal bone disease 1990: An unmet challenge for the nephrologist
    • Malluche H, Faugere MC. Renal bone disease 1990: an unmet challenge for the nephrologist. Kidney Int 1990; 38: 193-211.
    • (1990) Kidney Int , vol.38 , pp. 193-211
    • Malluche, H.1    Faugere, M.C.2
  • 16
    • 0027485515 scopus 로고
    • Aplastic osteodystrophy without aluminum: The role of suppressed parathyroid function
    • Hercz G, Pei Y, Greenwood C y cols. Aplastic osteodystrophy without aluminum: the role of «suppressed» parathyroid function. Kidney/nf 1993; 44: 860-866.
    • (1993) Kidney/nf , vol.44 , pp. 860-866
    • Hercz, G.1    Pei, Y.2    Greenwood, C.3
  • 17
    • 0035003729 scopus 로고    scopus 로고
    • Protein intake, control of serum phosphorus, and relatively low levels of parathyroid hormone in elderly hemodialysis patients
    • Lorenzo V, Martin M, Rufino M y cols. Protein intake, control of serum phosphorus, and relatively low levels of parathyroid hormone in elderly hemodialysis patients. Am J Kidney Dis 2002; 37:1260-1266.
    • (2002) Am J Kidney Dis , vol.37 , pp. 1260-1266
    • Lorenzo, V.1    Martin, M.2    Rufino, M.3
  • 18
    • 0029059351 scopus 로고
    • The contribution of acidosis to renal osteodystrophy
    • Bushinsky DA. The contribution of acidosis to renal osteodystrophy. Kidney Int 1995; 47: 1816-1832.
    • (1995) Kidney Int , vol.47 , pp. 1816-1832
    • Bushinsky, D.A.1
  • 19
    • 4644323860 scopus 로고    scopus 로고
    • Vascular calcification: A stiff challenge for the nephrologist: does preventing bone disease cause arterial disease?
    • Goldsmith D, Ritz E, Covic A. Vascular calcification: a stiff challenge for the nephrologist: does preventing bone disease cause arterial disease? Kidney Int 2004; 66: 1315-1333.
    • (2004) Kidney Int , vol.66 , pp. 1315-1333
    • Goldsmith, D.1    Ritz, E.2    Covic, A.3
  • 20
    • 0034682247 scopus 로고    scopus 로고
    • Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
    • Goodman WG, Goldin J, Kuizon BD y cols. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483.
    • (2000) N Engl J Med , vol.342 , pp. 1478-1483
    • Goodman, W.G.1    Goldin, J.2    Kuizon, B.D.3
  • 21
    • 0041318888 scopus 로고    scopus 로고
    • Cardiovascular calcifications in uremic patients: Clinical impact on cardiovascular function
    • London GM. Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function. J Am Soc Nephrol 2003; 14: S305-S309.
    • (2003) J Am Soc Nephrol , vol.14
    • London, G.M.1
  • 22
    • 0030967042 scopus 로고    scopus 로고
    • Atherosclerosis and arteriosclerosis in chronic renal failure
    • London GM, Drueke TB. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int 1997; 51: 1678-1695.
    • (1997) Kidney Int , vol.51 , pp. 1678-1695
    • London, G.M.1    Drueke, T.B.2
  • 23
    • 0036560596 scopus 로고    scopus 로고
    • Calciphylaxis: Emerging concepts in prevention, diagnosis, and treatment
    • Wilmer WA, Magro CM. Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment. Semin Dial 2002; 15: 172-186.
    • (2002) Semin Dial , vol.15 , pp. 172-186
    • Wilmer, W.A.1    Magro, C.M.2
  • 24
    • 0037337818 scopus 로고    scopus 로고
    • Uremia Induces the osteoblast differentiation factor Cbfa1 in human blood vessels
    • Moe SM, Duan D, Doehle BP y cols. Uremia Induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int 2003; 63: 1003-1011.
    • (2003) Kidney Int , vol.63 , pp. 1003-1011
    • Moe, S.M.1    Duan, D.2    Doehle, B.P.3
  • 25
    • 0036151662 scopus 로고    scopus 로고
    • Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins
    • Moe SM, O'Neill KD, Duan D y cols. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 2002; 61: 638-647.
    • (2002) Kidney Int , vol.61 , pp. 638-647
    • Moe, S.M.1    O'Neill, K.D.2    Duan, D.3
  • 26
    • 26944473687 scopus 로고    scopus 로고
    • Pathogenesis of vascular calcification in chronic kidney disease
    • Cozzolino M, Brancaccio D, Gallieni M, Slatopolsky E. Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int 2005; 68: 429-436.
    • (2005) Kidney Int , vol.68 , pp. 429-436
    • Cozzolino, M.1    Brancaccio, D.2    Gallieni, M.3    Slatopolsky, E.4
  • 27
    • 9644276844 scopus 로고    scopus 로고
    • Vascular calcification mechanisms
    • Giachelli CM. Vascular calcification mechanisms. J Am Soc Nephrol 2004; 15:2959-2964.
    • (2004) J Am Soc Nephrol , vol.15 , pp. 2959-2964
    • Giachelli, C.M.1
  • 29
    • 0033634633 scopus 로고    scopus 로고
    • Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification
    • Shearer MJ. Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Curr Opin Clin Nutr Metab Care 2000; 3: 433-438.
    • (2000) Curr Opin Clin Nutr Metab Care , vol.3 , pp. 433-438
    • Shearer, M.J.1
  • 31
    • 0032079445 scopus 로고    scopus 로고
    • Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
    • Bucay N, Sarosi I, Dunstan CR y cols. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998; 12: 1260-1268.
    • (1998) Genes Dev , vol.12 , pp. 1260-1268
    • Bucay, N.1    Sarosi, I.2    Dunstan, C.R.3
  • 32
    • 33645269267 scopus 로고    scopus 로고
    • Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification
    • Reynolds JL, Skepper JN, McNair R y cols. Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. JAm Soc Nep 2005; 16: 2920-2930.
    • (2005) JAm Soc Nep , vol.16 , pp. 2920-2930
    • Reynolds, J.L.1    Skepper, J.N.2    McNair, R.3
  • 33
    • 0037426081 scopus 로고    scopus 로고
    • Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study
    • Ketteler M, Bongartz P, Westenfeld R y cols. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003; 361: 827-833,.
    • (2003) Lancet , vol.361 , pp. 827-833
    • Ketteler, M.1    Bongartz, P.2    Westenfeld, R.3
  • 34
    • 0043037220 scopus 로고    scopus 로고
    • Vascular calcification: In vitro evidence for the role of inorganic phosphate
    • Giachelli CM. Vascular calcification: in vitro evidence for the role of inorganic phosphate. J Am Soc Nephrol 2003; 14: S300-S304.
    • (2003) J Am Soc Nephrol , vol.14
    • Giachelli, C.M.1
  • 35
    • 0034730291 scopus 로고    scopus 로고
    • Murry CEy cols. Phosphate regulation of vascular smooth muscle cell calcification
    • Jono S, McKee MD, Murry CEy cols. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87: E10-E17.
    • (2000) Circ Res , vol.87
    • Jono, S.1    McKee, M.D.2
  • 36
    • 14544283020 scopus 로고    scopus 로고
    • Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in ESRD
    • Reynolds JL, Joannides AJ, Skepper JN y cols. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004; 15: 2857-2867.
    • (2004) J Am Soc Nephrol , vol.15 , pp. 2857-2867
    • Reynolds, J.L.1    Joannides, A.J.2    Skepper, J.N.3
  • 38
    • 0032578442 scopus 로고    scopus 로고
    • 1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide
    • Jono S, Nishizawa Y, Shiol A, Morii H. 1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation 1998; 98: 1302-1306.
    • (1998) Circulation , vol.98 , pp. 1302-1306
    • Jono, S.1    Nishizawa, Y.2    Shiol, A.3    Morii, H.4
  • 39
    • 33750576187 scopus 로고    scopus 로고
    • Mortality risk among hemodialysis patients receiving different vitamin D analogs
    • Tentori F, Hunt WC, Stidley CA y cols. Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 2006; 70: 1858-1865.
    • (2006) Kidney Int , vol.70 , pp. 1858-1865
    • Tentori, F.1    Hunt, W.C.2    Stidley, C.A.3
  • 40
    • 0042343804 scopus 로고    scopus 로고
    • Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy
    • Teng M, Wolf M, Lowrie E y cols. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 2003; 349: 446-456.
    • (2003) N Engl J Med , vol.349 , pp. 446-456
    • Teng, M.1    Wolf, M.2    Lowrie, E.3
  • 41
    • 33947116127 scopus 로고    scopus 로고
    • Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology
    • Jindal K, Chan CT, Deziel C y cols. Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol 2006; 17: S1-27.
    • (2006) J Am Soc Nephrol , vol.17
    • Jindal, K.1    Chan, C.T.2    Deziel, C.3
  • 42
    • 1542287579 scopus 로고    scopus 로고
    • Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy
    • Martin KJ, Olgaard K, Coburn JW y cols. Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Dis 2004; 43: 558-565.
    • (2004) Am J Kidney Dis , vol.43 , pp. 558-565
    • Martin, K.J.1    Olgaard, K.2    Coburn, J.W.3
  • 43
    • 83055172414 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42: S1-201.
    • K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42: S1-201.
  • 45
    • 0027496973 scopus 로고
    • Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease
    • Hutchison AJ, Whitehouse RW, Boulton HF y cols. Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int 1993; 44: 1071-1077.
    • (1993) Kidney Int , vol.44 , pp. 1071-1077
    • Hutchison, A.J.1    Whitehouse, R.W.2    Boulton, H.F.3
  • 46
    • 33746125352 scopus 로고    scopus 로고
    • Inter-method variability in PTH measurement: Implication for the care of CKD patients
    • Souberbielle JC, Boutten A, Carlier MC y cols. Inter-method variability in PTH measurement: implication for the care of CKD patients. Kidney Int 2006; 350.
    • (2006) Kidney Int , pp. 350
    • Souberbielle, J.C.1    Boutten, A.2    Carlier, M.C.3
  • 47
    • 0033786216 scopus 로고    scopus 로고
    • Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites
    • Schomig M, Ritz E. Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites. Nephrol Dial Transplant 2000; 15: 18-24,.
    • (2000) Nephrol Dial Transplant , vol.15 , pp. 18-24
    • Schomig, M.1    Ritz, E.2
  • 48
    • 0037850084 scopus 로고    scopus 로고
    • Vitamin D status and secondary hyperparathyroidism: The importance of 25-hydroxyvitamin D cut-off levels
    • Gómez-Alonso C, Naves-Díaz ML, Fernández- Martín JL y cols. Vitamin D status and secondary hyperparathyroidism: the importance of 25-hydroxyvitamin D cut-off levels. Kidney Int 2003; Supl. 44-S48.
    • (2003) Kidney Int , Issue.SUPL. 44-S48
    • Gómez-Alonso, C.1    Naves-Díaz, M.L.2    Fernández- Martín, J.L.3
  • 49
    • 0242270888 scopus 로고    scopus 로고
    • Bone mineral density, biochemical markers and skeletal fractures In haemodialysis patients
    • Urena P, Bernard-Poenaru O, Ostertag A y cols. Bone mineral density, biochemical markers and skeletal fractures In haemodialysis patients. Nephrol Dial Transplant 2003; 18: 2325-2331.
    • (2003) Nephrol Dial Transplant , vol.18 , pp. 2325-2331
    • Urena, P.1    Bernard-Poenaru, O.2    Ostertag, A.3
  • 51
  • 52
    • 0029780445 scopus 로고    scopus 로고
    • Trends in renal osteodystrophy: A survey from 1983 to 1995 In a total of 2.248 patients
    • Monier-Faugere MC, Malluche HH. Trends in renal osteodystrophy: a survey from 1983 to 1995 In a total of 2.248 patients. Nephrol Dial Transplant 1996; 11 Supl. 3: 111 -120.
    • (1996) Nephrol Dial Transplant , vol.11 , Issue.SUPL. 3 , pp. 111-120
    • Monier-Faugere, M.C.1    Malluche, H.H.2
  • 53
    • 2942724370 scopus 로고    scopus 로고
    • A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients
    • Adragao T, Pires A, Lucas C y cols. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 1480-1488.
    • (2004) Nephrol Dial Transplant , vol.19 , pp. 1480-1488
    • Adragao, T.1    Pires, A.2    Lucas, C.3
  • 54
    • 0003171680 scopus 로고    scopus 로고
    • Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation
    • Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation.Am J Kidney Dis 2000; 35: S1-140.
    • (2000) Am J Kidney Dis , vol.35
  • 55
    • 6844251607 scopus 로고    scopus 로고
    • Is it possible to control hyperphosphataemia with diet, without inducing protein malnutrition?
    • Rufino M, De BE, Martín M y cols. Is it possible to control hyperphosphataemia with diet, without inducing protein malnutrition? Nephrol Dial Transplant 1998; 13 Supl. 3: 65-67.
    • (1998) Nephrol Dial Transplant , vol.13 , Issue.SUPL. 3 , pp. 65-67
    • Rufino, M.1    De, B.E.2    Martín, M.3
  • 56
    • 51349088036 scopus 로고    scopus 로고
    • Tratamiento Conservador de la Insuficiencia Renal Crónica. Hernando, L
    • Editorial Panamericana, Madrid
    • Lorenzo V, Torres A. Tratamiento Conservador de la Insuficiencia Renal Crónica. Hernando, L. 1997. Nefrología Clínica. Editorial Panamericana, Madrid.
    • (1997) Nefrología Clínica
    • Lorenzo, V.1    Torres, A.2
  • 57
    • 4344638044 scopus 로고    scopus 로고
    • A comparison of clinically useful phosphorus binders for patients with chronic kidney failure
    • Emmett M. A comparison of clinically useful phosphorus binders for patients with chronic kidney failure. Kidney Int 2004; Supl. S25-S32.
    • (2004) Kidney Int , Issue.SUPL.
    • Emmett, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.